Illness	Number of cases
Essential primary hypertension (I10.01)	261
Volume depletion (E86)	162
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	161
Heart failure (I50.01)	149
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	132
Left ventricular failure unspecified (I50.13)	116
Erysipelas (A46)	100
Gastritis and duodenitis (K29.1)	98
Chronic obstructive pulmonary disease with acute exacerbation (J44.19)	94
Syncope and collapse (R55)	87

Top 10 treatments

Treatment	Number
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	919
Computed tomography (CT) of the abdomen without contrast medium (3-207)	911
Computed tomography of the abdomen with contrast medium (3-225)	718
(9-984.7)	648
(9-984.8)	617
Computed tomography (CT) of the head without contrast medium (3-200)	616
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	582
Computed tomography of the chest with contrast medium (3-222)	464
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.a)	449
(9-984.9)	321

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
26	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
17	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility